Trop-2 inhibits prostate cancer cell adhesion to fibronectin through the β1 integrin-RACK1 axis

Journal of Cellular Physiology

Volumn 227, Issue 11, 2012, Pages 3670-3677

  Trerotola, Marco ^a,b   Li, Jing ^c   Alberti, Saverio ^d   Languino, Lucia R ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d Foundation University 'G d'Annunzio' DNI BAMS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHAVBETA5 INTEGRIN; BETA1 INTEGRIN; FOCAL ADHESION KINASE; PROTEIN; PROTEIN TROP 2; PROTEIN TYROSINE KINASE; RECEPTOR FOR ACTIVATED C KINASE 1; SHORT HAIRPIN RNA; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL ADHESION; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

ANTIGENS, CD29; ANTIGENS, NEOPLASM; CELL ADHESION; CELL ADHESION MOLECULES; CELL LINE, TUMOR; FIBRONECTINS; FOCAL ADHESION KINASE 1; GENE EXPRESSION REGULATION, NEOPLASTIC; GTP-BINDING PROTEINS; HUMANS; MALE; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 84864077186     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24074     Document Type: Article

References (65)

1. Acconcia F, Barnes CJ, Singh RR, Talukder AH, Kumar R. 2007. Phosphorylation-dependent regulation of nuclear localization and functions of integrin-linked kinase. Proc Natl Acad Sci USA 104: 6782-6787.
2. Akech J, Wixted JJ, Bedard K, van der Deen M, Hussain S, Guise TA, van Wijnen AJ, Stein JL, Languino LR, Altieri DC, Pratap J, Keller E, Stein GS, Lian JB. 2010. Runx2 association with progression of prostate cancer in patients: Mechanisms mediating bone osteolysis and osteoblastic metastatic lesions. Oncogene 29: 811-821.
3. Alam N, Goel HL, Zarif MJ, Butterfield JE, Perkins HM, Sansoucy BG, Sawyer TK, Languino LR. 2007. The integrin-growth factor receptor duet. J Cell Physiol 213: 649-653.
4. Balzar M, Briaire-de Bruijn IH, Rees-Bakker HA, Prins FA, Helfrich W, de Leij L, Riethmuller G, Alberti S, Warnaar SO, Fleuren GJ, Litvinov SV. 2001. Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions. Mol Cell Biol 21: 2570-2580.
5. 1 integrin epitope induced by soluble ligand and manganese, but inhibited by calcium. J Biol Chem 270: 25570-25577.
6. Besson A, Wilson TL, Yong VW. 2002. The anchoring protein RACK1 links protein kinase Cepsilon to integrin β chains. Requirements for adhesion and motility. J Biol Chem 277: 22073-22084.
7. Buensuceso CS, Woodside D, Huff JL, Plopper GE, O'Toole TE. 2001. The WD protein Rack1 mediates protein kinase C and integrin-dependent cell migration. J Cell Sci 114: 1691-1698.
8. Calvo A, Xiao N, Kang J, Best CJ, Leiva I, Emmert-Buck MR, Jorcyk C, Green JE. 2002. Alterations in gene expression profiles during prostate cancer progression: Functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors. Cancer Res 62: 5325-5335.
9. Chang BY, Conroy KB, Machleder EM, Cartwright CA. 1998. RACK1, a receptor for activated C kinase and a homolog of the β subunit of G proteins, inhibits activity of src tyrosine kinases and growth of NIH 3T3 cells. Mol Cell Biol 18: 3245-3256.
10. Chang BY, Chiang M, Cartwright CA. 2001. The interaction of Src and RACK1 is enhanced by activation of protein kinase C and tyrosine phosphorylation of RACK1. J Biol Chem 276: 20346-20356.
11. Clark EA, King WG, Brugge JS, Symons M, Hynes RO. 1998. Integrin-mediated signals regulated by members of the rho family of GTPases. J Cell Biol 142: 573-586.
12. Cox EA, Bennin D, Doan AT, O'Toole T, Huttenlocher A. 2003. RACK1 regulates integrin-mediated adhesion, protrusion, and chemotactic cell migration via its Src-binding site. Mol Biol Cell 14: 658-669.
13. Cox BD, Natarajan M, Stettner MR, Gladson CL. 2006. New concepts regarding focal adhesion kinase promotion of cell migration and proliferation. J Cell Biochem 99: 35-52.
14. DeRoock IB, Pennington ME, Sroka TC, Lam KS, Bowden GT, Bair EL, Cress AE. 2001. Synthetic peptides inhibit adhesion of human tumor cells to extracellular matrix proteins. Cancer Res 61: 3308-3313.
15. Engvall E, Ruoslahti E. 1977. Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer 20: 1-5.
16. Fong D, Moser P, Krammel C, Gostner JM, Margreiter R, Mitterer M, Gastl G, Spizzo G. 2008. High expression of TROP2 correlates with poor prognosis in pancreatic cancer. Br J Cancer 99: 1290-1295.
17. Fornaro M, Dell' Arciprete R, Stella M, Bucci C, Nutini M, Capri MG, Alberti S. 1995. Cloning of the gene encoding Trop-2, a cell-surface glycoprotein expressed by human carcinomas. Int J Cancer 62: 610-618.
18. 1 integrins. J Cell Biol 166: 407-418.
19. Goel HL, Li J, Kogan S, Languino LR. 2008. Integrins in prostate cancer progression. Endocr Relat Cancer 15: 657-664.
20. Goldstein AS, Lawson DA, Cheng D, Sun W, Garraway IP, Witte ON. 2008. Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proc Natl Acad Sci USA 105: 20882-20887.
21. Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON. 2010. Identification of a cell of origin for human prostate cancer. Science 329: 568-571.
22. Goswami A, Burikhanov R, de Thonel A, Fujita N, Goswami M, Zhao Y, Eriksson JE, Tsuruo T, Rangnekar VM. 2005. Binding and phosphorylation of par-4 by akt is essential for cancer cell survival. Mol Cell 20: 33-44.
23. 1 integrin cytoplasmic domain residues selectively modulate fibronectin matrix assembly and cell spreading through talin and Akt-1. J Biol Chem 284: 8148-8159.
24. Guerra E, Trerotola M, Dell' Arciprete R, Bonasera V, Palombo B, El-Sewedy T, Ciccimarra T, Crescenzi C, Lorenzini F, Rossi C, Vacca G, Lattanzio R, Piantelli M, Alberti S. 2008. A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer. Cancer Res 68: 8113-8121.
25. Hermanto U, Zong CS, Li W, Wang LH. 2002. RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix. Mol Cell Biol 22: 2345-2365.
26. 1 integrin cytodomain. J Cell Biol 157: 481-492.
27. Hynes RO. 2002. Integrins: Bidirectional, allosteric signaling machines. Cell 110: 673-687.
28. Kanchanawong P, Shtengel G, Pasapera AM, Ramko EB, Davidson MW, Hess HF, Waterman CM. 2010. Nanoscale architecture of integrin-based cell adhesions. Nature 468: 580-584.
29. Kiely PA, Sant A, O'Connor R. 2002. RACK1 is an insulin-like growth factor 1 (IGF-1) receptor-interacting protein that can regulate IGF-1-mediated Akt activation and protection from cell death. J Biol Chem 277: 22581-22589.
30. Kiely PA, Leahy M, O'Gorman D, O'Connor R. 2005. RACK1-mediated integration of adhesion and insulin-like growth factor I (IGF-I) signaling and cell migration are defective in cells expressing an IGF-I receptor mutated at tyrosines 1250 and 1251. J Biol Chem 280: 7624-7633.
31. Kiely PA, Baillie GS, Barrett R, Buckley DA, Adams DR, Houslay MD, O'Connor R. 2009. Phosphorylation of RACK1 on tyrosine 52 by c-Abl is required for insulin-like growth factor I-mediated regulation of focal adhesion kinase. J Biol Chem 284: 20263-20274.
32. 1-integrin-mediated advance but not for growth on poly-D-lysine. J Neurobiol 37: 524-540.
33. Kumar R, Gururaj AE, Barnes CJ. 2006. p21-activated kinases in cancer. Nat Rev Cancer 6: 459-471.
34. Lamoureux F, Thomas C, Yin MJ, Kuruma H, Fazli L, Gleave ME, Zoubeidi A. 2011. A novel HSP90 inhibitor delays castrate-resistant prostate cancer without altering serum PSA levels and inhibits osteoclastogenesis. Clin Cancer Res 17: 2301-2313.
35. Liliental J, Chang DD. 1998. Rack1, a receptor for activated protein kinase C, interacts with integrin β subunit. J Biol Chem 273: 2379-2383.
36. Litvinov SV, Balzar M, Winter MJ, Bakker HA, Briaire-de Bruijn IH, Prins F, Fleuren GJ, Warnaar SO, 1997. Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins. J Cell Biol 139: 1337-1348.
37. Lu TT, Barreuther M, Davis S, Madri JA. 1997. Platelet endothelial cell adhesion molecule-1 is phosphorylatable by c-Src, binds Src-Src homology 2 domain, and exhibits immunoreceptor tyrosine-based activation motif-like properties. J Biol Chem 272: 14442-14446.
38. Marx M, Warren SL, Madri JA. 2001. pp60(c-src) modulates microvascular endothelial phenotype and in vitro angiogenesis. Exp Mol Pathol 70: 201-213.
39. Mitra SK, Schlaepfer DD. 2006. Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol 18: 516-523.
40. Mitra SK, Hanson DA, Schlaepfer DD. 2005. Focal adhesion kinase: In command and control of cell motility. Nat Rev Mol Cell Biol 6: 56-68.
41. Nakatsukasa M, Kawasaki S, Yamasaki K, Fukuoka H, Matsuda A, Tsujikawa M, Tanioka H, Nagata-Takaoka M, Hamuro J, Kinoshita S. 2010. Tumor-associated calcium signal transducer 2 is required for the proper subcellular localization of claudin 1 and 7: Implications in the pathogenesis of gelatinous drop-like corneal dystrophy. Am J Pathol 177: 1344-1355.
42. Natarajan M, Stewart JE, Golemis EA, Pugacheva EN, Alexandropoulos K, Cox BD, Wang W, Grammer JR, Gladson CL. 2006. HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells. Oncogene 25: 1721-1732.
43. Ohmachi T, Tanaka F, Mimori K, Inoue H, Yanaga K, Mori M. 2006. Clinical significance of TROP2 expression in colorectal cancer. Clin Cancer Res 12: 3057-3063.
44. Palazzo AF, Eng CH, Schlaepfer DD, Marcantonio EE, Gundersen GG. 2004. Localized stabilization of microtubules by integrin- and FAK-facilitated Rho signaling. Science 303: 836-839.
45. 5 monoclonal antibodies. J Cell Sci 105: 101-111.
46. Price LS, Leng J, Schwartz MA, Bokoch GM. 1998. Activation of Rac and Cdc42 by integrins mediates cell spreading. Mol Biol Cell 9: 1863-1871.
47. Pytela R, Pierschbacher MD, Ruoslahti E. 1985. Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor. Cell 40: 191-198.
48. Ren XD, Kiosses WB, Sieg DJ, Otey CA, Schlaepfer DD, Schwartz MA. 2000. Focal adhesion kinase suppresses Rho activity to promote focal adhesion turnover. J Cell Sci 113: 3673-3678.
49. Ripani E, Sacchetti A, Corda D, Alberti S. 1998. Human Trop-2 is a tumor-associated calcium signal transducer. Int J Cancer 76: 671-676.
50. Ron D, Chen CH, Caldwell J, Jamieson L, Orr E, Mochly-Rosen D. 1994. Cloning of an intracellular receptor for protein kinase C: A homolog of the β subunit of G proteins. Proc Natl Acad Sci USA 91: 839-843.
51. Ruoslahti E. 1999. Fibronectin and its integrin receptors in cancer. Adv Cancer Res 76: 1-20.
52. Serrels B, Sandilands E, Serrels A, Baillie G, Houslay MD, Brunton VG, Canel M, Machesky LM, Anderson KI, Frame MC. 2010. A complex between FAK, RACK1, and PDE4D5 controls spreading initiation and cancer cell polarity. Curr Biol 20: 1086-1092.
53. Siu MK, Chan HY, Kong DS, Wong ES, Wong OG, Ngan HY, Tam KF, Zhang H, Li Z, Chan QK, Tsao SW, Stromblad S, Cheung AN. 2010. p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients. Proc Natl Acad Sci USA 107: 18622-18627.
54. Symons M, Settleman J. 2000. Rho family GTPases: More than simple switches. Trends Cell Biol 10: 415-419.
55. Trebak M, Begg GE, Chong JM, Kanazireva EV, Herlyn D, Speicher DW. 2001. (Ep-CAM/EGP40) and its role in GA733-mediated homotypic cell-cell adhesion. Oligomeric state of the colon carcinoma-associated glycoprotein GA733-732. J Biol Chem 276: 2299-2309.
56. 1 integrin surface receptors as markers of putative human prostate cancer stem cells. Am J Transl Res 2: 135-144.
57. Trerotola M, Cantanelli P, Guerra E, Tripaldi R, Aloisi AL, Bonasera V, La Sorda R, Lattanzio R, de Lange R, Weidle U, Piantelli M, Alberti S. 2012. Up-regulation of Trop-2 quantitatively stimulates human cancer growth. Oncogene Epub Feb 20.
58. Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, Parsons JT, Horwitz AF. 2004. FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol 6: 154-161.
59. Wells CM, Whale AD, Parsons M, Masters JR, Jones GE. 2010. PAK4: A pluripotent kinase that regulates prostate cancer cell adhesion. J Cell Sci 123: 1663-1673.
60. Winter MJ, Cirulli V, Briaire-de Bruijn IH, Litvinov SV. 2007. Cadherins are regulated by Ep-CAM via phosphaditylinositol-3 kinase. Mol Cell Biochem 302: 19-26.
61. Wu JD, Haugk K, Woodke L, Nelson P, Coleman I, Plymate SR. 2006. Interaction of IGF signaling and the androgen receptor in prostate cancer progression. J Cell Biochem 99: 392-401.
62. Yeatman TJ. 2004. A renaissance for SRC. Nat Rev Cancer 4: 470-480.
63. Zanna P, Trerotola M, Vacca G, Bonasera V, Palombo B, Guerra E, Rossi C, Lattanzio R, Piantelli M, Alberti S. 2007. Trop-1 are conserved growth stimulatory molecules that mark early stages of tumor progression. Cancer 110: 452-464.
64. 3 integrin is modulated by a focal adhesion kinase pathway. Cancer Res 59: 1655-1664.
65. Zoubeidi A, Zardan A, Wiedmann RM, Locke J, Beraldi E, Fazli L, Gleave ME. 2010. Hsp27 promotes insulin-like growth factor-I survival signaling in prostate cancer via p90Rsk-dependent phosphorylation and inactivation of BAD. Cancer Res 70: 2307-2317.